Mathias Møllebæk

Mathias Møllebæk

Postdoc

Member of:

    ORCID: 0000-0001-9960-9024

    Publication year:
    All
    1 - 4 out of 4Page size: 10
    1. 2024
    2. Published

      Targeting with digital biomarkers and digital therapeutics: Epistemic and regulatory shifts

      Møllebæk, Mathias, 2024.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    3. 2022
    4. Published

      Marketing authorization pathways and clinical evidence supporting approval of orphan medicinal products in EU between January 2015 and October 2021

      Hallgreen, Christine Erikstrup, Møllebæk, Mathias & Corap, E., 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 266-267

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    5. 2019
    6. Published

      POST-MARKETING RISK COMMUNICATION: HOW DO DANISH GPS READ LETTERS FROM REGULATORS AND INDUSTRY ABOUT EMERGENT RISKS?

      Møllebæk, Mathias, Kaae, Susanne & Villadsen, L. S., Dec 2019, p. E46-E46.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    7. 2017
    8. Published

      Public hearings as a transparency measure: The Valproate case

      Møllebæk, Mathias, 2 Oct 2017.

      Research output: Contribution to conference › Conference abstract for conference › Research

    ID: 170489612